OBINUTUZUMAB

obinutuzumab 1 g/40 mL injection, 40 mL vial

OBINUTUZUMAB (12193R)

obinutuzumab 1 g/40 mL injection, 40 mL vial
12193R
Body System:
Manner of administration:Injection
Private
Chemotherapy Items for Private Hospital use
Authority Required (STREAMLINED)

Restriction  18685

Indication: Chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL)
Treatment phase: For combination use with venetoclax treatment cycles 1 to 6 inclusive in first-line therapy
Quantities & Cost
Max amount # of repeats DPMA Max safety net General Patient Charge
Max amount: 1000 mg # of repeats: 8 DPMA: $4,496.33 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Gazyva
(obinutuzumab 1 g/40 mL injection, 40 mL vial)